- Home
- CRNT vs PRQR Comparison
CRNT vs PRQR Comparison
Compare CRNT & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- PRQR
- Stock Information
- Founded
- CRNT 1996
- PRQR 2012
- Country
- CRNT Israel
- PRQR Netherlands
- Employees
- CRNT N/A
- PRQR N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- CRNT Technology
- PRQR Health Care
- Exchange
- CRNT Nasdaq
- PRQR Nasdaq
- Market Cap
- CRNT 218.8M
- PRQR 179.1M
- IPO Year
- CRNT 2000
- PRQR 2014
- Fundamental
- Price
- CRNT $2.45
- PRQR $2.35
- Analyst Decision
- CRNT Strong Buy
- PRQR Strong Buy
- Analyst Count
- CRNT 5
- PRQR 8
- Target Price
- CRNT $5.85
- PRQR $8.88
- AVG Volume (30 Days)
- CRNT 728.3K
- PRQR 357.1K
- Earning Date
- CRNT 08-06-2025
- PRQR 08-07-2025
- Dividend Yield
- CRNT N/A
- PRQR N/A
- EPS Growth
- CRNT 367.84
- PRQR N/A
- EPS
- CRNT 0.25
- PRQR N/A
- Revenue
- CRNT $394,344,000.00
- PRQR $21,212,711.00
- Revenue This Year
- CRNT $3.12
- PRQR N/A
- Revenue Next Year
- CRNT $7.89
- PRQR N/A
- P/E Ratio
- CRNT $9.86
- PRQR N/A
- Revenue Growth
- CRNT 11.94
- PRQR 85.91
- 52 Week Low
- CRNT $1.95
- PRQR $1.07
- 52 Week High
- CRNT $5.73
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- CRNT 59.42
- PRQR 66.90
- Support Level
- CRNT $2.53
- PRQR $2.10
- Resistance Level
- CRNT $2.49
- PRQR $2.18
- Average True Range (ATR)
- CRNT 0.10
- PRQR 0.13
- MACD
- CRNT 0.02
- PRQR 0.01
- Stochastic Oscillator
- CRNT 83.72
- PRQR 56.92
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.